Preventive effect of Piracetam and Vinpocetine on hypoxia-reoxygenation induced injury in primary hippocampal culture

Food and Chemical Toxicology

Volumn 49, Issue 4, 2011, Pages 917-922

  Solanki, P ^a   Prasad, D ^a   Muthuraju, S ^a   Sharma, A K ^a   Singh, S B ^a   Ilavzhagan, G ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

Hypoxia; Oxidative stress; Piracetam; Primary hippocampal culture; Reoxygenation; Vinpocetine

Indexed keywords

ACETYLCHOLINESTERASE; CARBON DIOXIDE; GLUTATHIONE; GLUTATHIONE DISULFIDE; LACTATE DEHYDROGENASE; OXYGEN; PIRACETAM; REACTIVE OXYGEN METABOLITE; VINPOCETINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN HYPOXIA; BRAIN INJURY; BRAIN PROTECTION; CELL HYPOXIA; CELL STRESS; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME RELEASE; HIPPOCAMPUS; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; RAT; REOXYGENATION; REPERFUSION INJURY;

ACETYLCHOLINESTERASE; ANIMALS; ANOXIA; ANTIOXIDANTS; HIPPOCAMPUS; L-LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PIRACETAM; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; VINCA ALKALOIDS;

EID: 79952438100     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.12.015     Document Type: Article

References (31)

1. Abramov A.Y., Scorziello A., Duchen M.R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J. Neurosci. 2007, 27:1129-1138.
2. Acker T., Acker H. Cellular oxygen sensing need in CNS function: physiological and pathological implications. J. Exp. Biol. 2004, 207:3171-3188.
3. Aksenova M.V., Aksenov M.Y., Mactutus C.F., Booze R.M. Cell culture models of oxidative stress and injury in the central nervous system. Curr. Neurovasc. Res. 2005, 2:73-89.
4. Cathcert R., Schweirs E., Ames B.N. Detection of picomole levels of hydroperoxides using fluorescence dichlorofluorescein assay. Annu. Biochem. Exp. Med. 1983, 137:111-116.
5. Contestabile A. Oxidative stresses in neurodegeneration: mechanisms and therapeutic perspectives. Curr. Top. Med. Chem. 2001, 6:553-568.
6. Eckert G.P., Cairns N.J., Muller W.E. Piracetam reverses hippocampal membrane alterations in Alzheimer's disease. J. Neural Transm. 1999, 106:757-761.
7. Eichler J., Silman I. The activity of an endoplasmic reticulum-localized pool of acetylcholinesterase is modulated by heat shock. J. Biol. Chem. 1995, 270:4466-4472.
8. Fedi M., Reutens D., Dubeau F., Andermann E., D'Agostino D., Andermann F. Long-term efficacy and safety of Piracetam in the treatment of progressive myoclonus epilepsy. Arch. Neurol. 2001, 58:781-786.
9. Fischhof P.K., Moslinger-Gehmayr R., Herrmann W.M., Friedmann A., Russmann D.L. Therapeutic efficacy of vincamine in dementia. Neuropsychobiology 1996, 34:29-35.
10. Gabryel B., Adamek M., Pudelko A., Malecki A., Trzeciak H.I. Piracetam and Vinpocetine exert cytoprotective activity and prevent apoptosis of astrocytes in vitro in hypoxia and reoxygenation. Neurotoxicology 2002, 23:19-31.
11. Hissin P.H., Hilf R.A. Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976, 74:214-226.
12. Jayalakshmi K., Sairam M., Singh S.B., Sharma S.K., Ilavazhagan G., Banerjee P.K. Neuroprotective effect of N-acetyl cysteine on hypoxia-induced oxidative stress in primary hippocampal culture. Brain Res. 2005, 1046:97-104.
13. Jiang H., Zhang J., Zhu H., Li H., Zhang X. Nerve Growth Factor Prevents the Apoptosis-associated increase in Acetylcholinesterase activity after hydrogen peroxide treatment by activating Akt. Acta bioch. Bioph. Sin. 2007, 39:46-56.
14. Keil K., Scherping I., Hauptmann S., Schuessel K., Eckert A., Muller W.E. Piracetam improves mitochondrial dysfunction following oxidative stress. Br. J. Pharmacol. 2006, 147:199-208.
15. Kessler J., Thiel A., Karbe H., Heiss W.D. Piracetam improves activated blood flow and facilitates rehabilitation of post-stroke aphasic patients. Stroke 2000, 31:2112-2116.
16. Kiss B., Karpati E. Mechanism of action of Vinpocetine. Acta Pharm. Hung. 1996, 66:213-224.
17. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 1987, 20:83-99.
18. Lakics V., Sebestyen M.G., Erdo S.L. Vinpocetine is a highly potent neuroprotectant against veratridine-induced cell death in primary cultures of rat cerebral cortex. Neurosci. Lett. 1995, 185:127-130.
19. Lievre V., Becuwe P., Bianchi A., Bossenmeyer-Pourié C., Koziel V., Franck P., Nicolas M.B., Dauça M., Vert P., Daval J.L. Intracellular generation of free radicals and modifications of detoxifying enzymes in cultures neurons from the developing rat forebrain in response to transient hypoxia. Neuroscience 2001, 105:287-297.
20. Lowry O.H., Resebrough N., Randal R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
21. Maiti P., Singh S.B., Sharma A.K., Muthuraju S., Banerjee P.K., Ilavazhagan G. Hypobaric hypoxia induces oxidative stress in rat brain. Neurochem. Int. 2006, 49:709-716.
22. Marini H., Costa C., Passaniti M., Esposito M., Campo G.M., Ientile R., Adamo E.B., Marini R., Calabresi P., Altavilla D., Minutoli L., Pisani F., Squadrito F. Levetiracetam protects against kainic acid-induced toxicity. Life Sci. 2004, 74:1253-1264.
23. Molochkina E.M., Zorina O.M., Fatkullina L.D., Goloschapov A.N., Burlakova E.B. H2O2 modifies membrane structure and activity of acetylcholinesterase. Chem. Biol. Interact. 2005, 157-158:401-404.
24. Muller W.E., Eckert G.P., Eckert A. Piracetam: novelty in a unique mode of action. Pharmacopsychiatry 1999, 32:2-9.
25. Olah V.A., Balla G., Balla J., Szabolcs A., Karmazsin L. An in vitro study of the hydroxyl scavenger effect of Vinpocetine. Acta Paediatr. Hung. 1990, 30:309-316.
26. Santos M.S., Duarte A.I., Moreira P.I., Oliveira C.R. Synaptosomal response to oxidative stress: effect of Vinpocetine. Free Radic. Res. 2000, 32:57-66.
27. Scaduto R.C., Lee W. Measurement of mitochondrial membrane potential using fluorescent Rhodamine derivatives. Biophys. J. 1999, 76:469-477.
28. Sunanda B.S., Shankaranarayana R., Raju T.R. Corticosterone attenuates zinc induced neurotoxicity in primary hippocampal culture. Brain Res. 1998, 791:295-298.
29. Waegemans T., Wilsher C.R., Danniau A., Ferris S.H., Kurz A., Winblad B. Clinical efficacy of Piracetam in cognitive impairment: a meta-analysis. Dement. Geriatr. Cogn. Disord. 2002, 13:217-224.
30. Zelles T., Franklin L., Koncz I., Lendvai B., Zsilla G. The nootropic drug Vinpocetine inhibits veratridine-induced [Ca2+] increase in rat hippocampal CA1 pyramidal cells. Neurochem. Res. 2001, 26:1095-1100.
31. Zhu H., Gao W., Jiang H., Jin Q.H., Shi Y.F., Tsim K.W., Zhang X.J. Regulation of acetylcholinesterase expression by calcium signaling during calcium ionophore A23187- and thapsigargin-induced apoptosis. Int. J. Biochem. Cell Biol. 2007, 39:93-108.